Finch RA - Search Results

1

Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.

Li J, Finch RA, Sartorelli AC. Li J, et al. Among authors: finch ra. Exp Cell Res. 1999 Jun 15;249(2):279-90. doi: 10.1006/excr.1999.4475. Exp Cell Res. 1999. PMID: 10366427 Free article.

2

Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid-treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiation.

Finch RA, Li J, Chou TC, Sartorelli AC. Finch RA, et al. Blood. 2000 Sep 15;96(6):2262-8. Blood. 2000. PMID: 10979975 Free article.

3

Identification of a repressor of the differentiation of WEHI-3B D- leukemia cells.

Li J, Finch RA, Xiao W, Sartorelli AC. Li J, et al. Among authors: finch ra. Exp Cell Res. 1998 Jul 10;242(1):274-84. doi: 10.1006/excr.1998.4106. Exp Cell Res. 1998. PMID: 9665825 Free article.

4

Comparative study of the importance of multidrug resistance-associated protein 1 and P-glycoprotein to drug sensitivity in immortalized mouse embryonic fibroblasts.

Lin ZP, Johnson DR, Finch RA, Belinsky MG, Kruh GD, Sartorelli AC. Lin ZP, et al. Among authors: finch ra. Mol Cancer Ther. 2002 Oct;1(12):1105-14. Mol Cancer Ther. 2002. PMID: 12481434

5

Muramatsu T, Johnson DR, Finch RA, Johnson LK, Leffert JJ, Lin ZP, Pizzorno G, Sartorelli AC. Muramatsu T, et al. Among authors: finch ra. Oncol Res. 2004;14(7-8):331-43. doi: 10.3727/0965040041292387. Oncol Res. 2004. PMID: 15301424

6

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.

Finch RA, Liu M, Grill SP, Rose WC, Loomis R, Vasquez KM, Cheng Y, Sartorelli AC. Finch RA, et al. Biochem Pharmacol. 2000 Apr 15;59(8):983-91. doi: 10.1016/s0006-2952(99)00419-0. Biochem Pharmacol. 2000. PMID: 10692563 Free article.

7

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes.

Robbiani DF, Finch RA, Jäger D, Muller WA, Sartorelli AC, Randolph GJ. Robbiani DF, et al. Among authors: finch ra. Cell. 2000 Nov 22;103(5):757-68. doi: 10.1016/s0092-8674(00)00179-3. Cell. 2000. PMID: 11114332 Free article.

8

The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice.

Johnson DR, Finch RA, Lin ZP, Zeiss CJ, Sartorelli AC. Johnson DR, et al. Among authors: finch ra. Cancer Res. 2001 Feb 15;61(4):1469-76. Cancer Res. 2001. PMID: 11245453

9

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.

Finch RA, Shyam K, Penketh PG, Sartorelli AC. Finch RA, et al. Cancer Res. 2001 Apr 1;61(7):3033-8. Cancer Res. 2001. PMID: 11306484

10

Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.

Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, Sartorelli AC. Lorico A, et al. Among authors: finch ra. Cancer Res. 1997 Dec 1;57(23):5238-42. Cancer Res. 1997. PMID: 9393741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters